| Literature DB >> 23802650 |
Seung Bin Cha1, Won Jung Lee, Min Kyoung Shin, Myung Hwan Jung, Seung Won Shin, An Na Yoo, Jong Wan Kim, Han Sang Yoo.
Abstract
BACKGROUND: Brucella abortus is an intracellular zoonotic pathogen which causes undulant fever, endocarditis, arthritis and osteomyelitis in human and abortion and infertility in cattle. This bacterium is able to invade and replicate in host macrophage instead of getting removed by this defense mechanism. Therefore, understanding the interaction between virulence of the bacteria and the host cell is important to control brucellosis. Previously, we generated internalization defective mutants and analyzed the envelope proteins. The present study was undertaken to evaluate the changes in early transcriptional responses between wild type and internalization defective mutants infected mouse macrophage, RAW 264.7.Entities:
Mesh:
Year: 2013 PMID: 23802650 PMCID: PMC3716731 DOI: 10.1186/1471-2164-14-426
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Primers used for qRT-PCR
| NM_008392.1 | Irg1 (Immunoresponsive gene 1) | CCTGTGCCTCGCTGCTCGAC | CGTGTCGAAGCTTGGCGGGT |
| NM_007987.2 | Fas (TNF receptor superfamily member 6) | CCTGCGCCCCATGCACAGAA | TCTGGGTCAGGGTGCAGTTTGT |
| NM_013652.2 | Ccl4 (Chemokine (C-C motif) ligand 4) | GCTCTGCGTGTCTGCCCTCTC | TGGTGCTGAGAACCCTGGAGCA |
| NM_139154.2 | Rab40c (Rab40c, member RAS oncogene family) | GACGGCGCAGCTGAATCCCC | CCAGCTTGACACGCCGTCCA |
| NM_028724.4 | Rin2 (Ras and Rab interactor 2) | TCTGCCCTGCCTCCTTGCGT | GCACTCCAGCTCCGAAGGCG |
| NM_023635.5 | Rab27a (Rab27a, member RAS oncogene family) | AAAAGGCCAGTCGCACGGGG | TGTCCCTGCGGTGTTGCGTC |
| NM_008084.2 | Gapdh (Glyceraldehyde-3-phosphate dehydrogenase) | CCCCAGCAAGGACACTGAGCAAG | TGGGGGTCTGGGATGGAAATTGTG |
Figure 1Count of genes with up and down regulated compare to uninfected macrophage. (p < 0.05, |fold change | ≥ 1.5).
The 20 most up-regulated genes in mouse macrophage cell line RAW 264.7 infected with each compare to uninfected macrophage
| Cxcl2 | Chemokine (C-X-C motif) ligand 2 | 34.68 | 1.56E-193 | 21.51 | 1.54E-156 | 33.41 | 7.14E-220 | 43.82 | 5.67E-166 | 29.62 | 4.21E-205 |
| Tnf | Tumor necrosis factor | 17.47 | 4.45E-150 | 14.18 | 3.82E-133 | 21.83 | 1.58E-168 | 22.45 | 6.39E-120 | 18.35 | 3.46E-157 |
| Nfkbiz | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 15.58 | 3.68E-118 | 11.51 | 1.42E-100 | 18.61 | 3.69E-151 | 17.88 | 3.63E-96 | 14.34 | 1.80E-128 |
| Irg1 | Immunoresponsive gene 1 | 12.29 | 2.47E-99 | 8.82 | 9.26E-80 | 10.29 | 4.04E-96 | 14.74 | 1.45E-83 | 11.29 | 1.04E-106 |
| Ier3 | Immediate early response 3 | 8.35 | 4.93E-82 | 6.36 | 1.01E-63 | 9.03 | 7.44E-87 | 9.04 | 1.02E-55 | 7.6 | 2.81E-78 |
| Traf1 | NOD-derived CD11c + ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630118K07 product: Tnf receptor-associated factor 1, full insert sequence | 8.13 | 5.31E-56 | 5.68 | 3.78E-37 | 7.3 | 1.67E-58 | 9.22 | 1.21E-56 | 7.54 | 1.42E-66 |
| Phlda1 | Pleckstrin homology-like domain, family A, member 1 | 6.56 | 3.88E-53 | 5.04 | 8.66E-43 | 6.97 | 4.86E-67 | 7.27 | 3.88E-45 | 6.49 | 9.56E-62 |
| Gpr84 | G protein-coupled receptor 84 | 6.30 | 9.74E-59 | 5.36 | 2.85E-50 | 6.74 | 1.83E-64 | 7..45 | 1.48E-45 | 6.48 | 1.31E-67 |
| Ccl2 | Chemokine (C-C motif) ligand 2 | 6.16 | 4.74E-50 | 4.03 | 1.50E-31 | 5.2 | 2.46E-48 | 6.16 | 9.30E-38 | 5.14 | 3.57E-47 |
| Ccl7 | Chemokine (C-C motif) ligand 7 | 5.26 | 8.97E-32 | 3.48 | 2.07E-18 | 3.68 | 7.03E-21 | 5.91 | 5.23E-36 | 4.85 | 1.48E-39 |
| Il1b | Interleukin 1 beta | 4.89 | 2.78E-26 | 2.87 | 5.56E-13 | 3.63 | 2.88E-20 | 6.12 | 1.95E-37 | 4.29 | 6.18E-33 |
| Gpr109a | Niacin receptor 1 | 4.45 | 2.13E-23 | 3.31 | 5.81E-17 | 3.73 | 4.66E-21 | 5.38 | 3.27E-32 | 4.43 | 8.81E-35 |
| Cish | Cytokine inducible SH2-containing protein | 4.43 | 4.39E-23 | 3.0 | 3.85E-14 | 3.83 | 6.24E-22 | 5.35 | 5.20E-32 | 4.21 | 2.63E-32 |
| Marcksl1 | MARCKS-like 1 | 4.32 | 2.26E-29 | 3.29 | 6.83E-19 | 4.27 | 1.75E-35 | 4.76 | 1.14E-27 | 4.27 | 2.45E-35 |
| Cd83 | CD83 antigen | 4.01 | 7.25E-26 | 3.31 | 4.48E-19 | 4.32 | 3.18E-36 | 4.47 | 1.92E-25 | 3.94 | 2.74E-31 |
| Il4i1 | Interleukin 4 induced 1 | 4.0 | 3.19E-20 | 3.11 | 4.16E-15 | 3.64 | 2.06E-20 | 4.56 | 4.58E-26 | 3.88 | 8.18E-29 |
| Socs3 | Suppressor of cytokine signaling 3 | 3.66 | 1.95E-20 | 2.45 | 3.55E-09 | 3.78 | 1.80E-26 | 4.93 | 6.06E-29 | 3.05 | 1.49E-19 |
| Nfkbia | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 3.58 | 1.78E-22 | 3.34 | 2.00E-21 | 4.25 | 1.50E-36 | 4.46 | 2.12E-25 | 3.73 | 2.96E-29 |
| Edn1 | Endothelin 1 | 3.53 | 2.85E-16 | 2.28 | 8.95E-08 | 2.49 | 5.74E-10 | 3.51 | 1.20E-17 | 2.84 | 1.34E-15 |
| Ehd1 | EH-domain containing 1 | 3.45 | 8.17E-17 | 2.83 | 1.43E-12 | 3.22 | 2.12E-17 | 4.01 | 1.02E-21 | 3.5 | 1.30E-24 |
The 20 most down-regulated in mouse macrophage cell line RAW 264.7 infected with each compare to uninfected macrophage
| Cytip | Cytohesin 1 interacting protein | −2.9 | 1.62E-11 | −2.16 | 1.08E-06 | −2.35 | 1.19E-08 | −2.82 | 6.46E-12 | −2.53 | 3.53E-13 |
| Cxcr4 | Chemokine (C-X-C motif) receptor 4 | −2.17 | 6.43E-06 | −1.81 | 8.36E-04 | −2.13 | 9.94E-07 | −2.63 | 2.59E-10 | −2.12 | 4.46E-07 |
| Klhl6 | Kelch-like 6 (Drosophila) | −2.1 | 5.71E-07 | −1.73 | 3.39E-04 | −1.73 | 8.32E-05 | −2.15 | 2.06E-06 | −1.91 | 1.06E-06 |
| Enc1 | Ectodermal-neural cortex 1 | −2.01 | 1.01E-04 | −1.77 | 1.71E-03 | −1.9 | 1.03E-04 | −1.98 | 5.11E-05 | −1.98 | 9.61E-07 |
| Slc40a1 | Solute carrier family 40 (iron-regulated transporter), member 1 | −1.95 | 5.21E-06 | −1.83 | 2.61E-05 | −1.8 | 1.17E-05 | −2.31 | 1.15E-07 | −1.92 | 6.60E-07 |
| Tmem86a | Transmembrane protein 86A | −1.85 | 1.23E-03 | −1.51 | >0.05 | −1.79 | 7.58E-04 | −2.02 | 2.43E-05 | −1.79 | 4.44E-04 |
| BC039093 | cDNA sequence BC039093 | −1.84 | 9.07E-04 | −1.54 | >0.05 | −1.7 | 2.06E-03 | −1.92 | 1.33E-04 | −1.73 | 1.73E-04 |
| 5430435G22Rik | RIKEN cDNA 5430435G22 gene | −1.81 | 2.26E-03 | −1.57 | 0.04 | −1.74 | 1.90E-03 | −1.93 | 1.25E-04 | −1.68 | 5.34E-04 |
| Tmem51 | Transmembrane protein 51 | −1.81 | 3.69E-04 | −1.57 | 0.01 | −1.65 | 8.54E-04 | −2.08 | 9.03E-06 | −1.86 | 4.84E-06 |
| Lhfpl2 | Lipoma HMGIC fusion partner-like 2 | −1.78 | 1.60E-04 | −1.52 | 0.02 | −1.8 | 8.18E-06 | −1.96 | 6.97E-05 | −1.82 | 6.49E-06 |
| Slc37a1 | 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732478E01 product:solute carrier family 37 (glycerol-3-phosphate transporter), member 1, full insert sequence | −1.78 | 3.92E-03 | −1.57 | 0.04 | −1.61 | 0.02 | −1.8 | 1.16E-03 | −1.73 | 2.98E-04 |
| C130050O18Rik | RIKEN cDNA C130050O18 gene | −1.78 | 3.88E-03 | −1.62 | 0.02 | −1.85 | 2.48E-04 | −1.94 | 1.12E-04 | −1.81 | 1.05E-04 |
| AI595366 | Leucine rich repeat containing 14B | −1.77 | 3.95E-03 | −1.51 | >0.05 | −1.59 | 0.02 | −1.85 | 4.90E-04 | −1.63 | 0.01 |
| B930041F14Rik | RIKEN cDNA B930041F14 gene | −1.75 | 4.00E-03 | −1.54 | >0.05 | −1.67 | 3.77E-03 | −1.87 | 3.39E-04 | −1.74 | 1.36E-04 |
| LOC100045981 | Similar to synaptotagmin XI | −1.74 | 5.45E-03 | −1.58 | 0.04 | −1.65 | 6.70E-03 | −1.97 | 5.60E-05 | −1.85 | 1.29E-05 |
| Arrdc3 | Arrestin domain containing 3 | −1.74 | 6.50E-03 | −1.6 | 0.03 | −1.71 | 2.72E-03 | −1.95 | 9.29E-05 | −1.55 | 0.02 |
| Tspan14 | Tetraspanin 14 | −1.73 | 1.60E-03 | −1.43 | >0.05 | −1.45 | 0.04 | −1.72 | 4.53E-03 | −1.52 | 0.01 |
| Lzts2 | Leucine zipper, putative tumor suppressor 2 | −1.72 | 8.22E-03 | −1.63 | 0.02 | −1.74 | 1.82E-03 | −1.87 | 3.22E-04 | −1.76 | 9.06E-04 |
| Fblim1 | Filamin binding LIM protein 1 | −1.72 | 2.29E-03 | −1.53 | 0.04 | −1.49 | 0.02 | −1.61 | 0.02 | −1.56 | 5.47E-03 |
| Phf17 | PHD finger protein 17 | −1.7 | 0.01 | −1.59 | 0.03 | −1.62 | 0.01 | −1.72 | 4.73E-03 | −1.55 | 8.58E-03 |
Figure 2Categorization by biological process of genes with significantly regulated transcripts in RAW 264.7 macrophage at 4 h post infection of each strains. Up-regulated transcripts (A) and down-regulated transcripts (B). (P < 0.05, fisher’s exact test).
Figure 3Categorization by molecular function of genes with significantly regulated transcripts in RAW 264.7 macrophage at 4 h post infection of each strains. Up-regulated transcripts (A) and down-regulated transcripts (B). (P < 0.05, fisher’s exact test).
Figure 4Plots of the expression level between wild type infected cell versus mutant infected cell. Red dots indicate an expression level change of ≥1.5 or ≤1.5 fold of both up- and down- regulated genes. Expression level was calculated by base 2 logarithm of normalized hybridization signals from each sample.
Figure 5Validation of microarray data by quantitative RT-PCR. The relative expression level was normalized by Gapdh expression level and relative to uninfected cells. RT-PCR data were averaged from three independent RNA isolation and presented as mean relative expression with an error bar which represents SEM.